NYSE: ABBV
AbbVie Inc Stock Ownership

Insider buying vs selling

Have AbbVie Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Henry O. GosebruchEVP Chief Strategy Officer2020-11-2433,100$99.49
$3.29MSell
Henry O. GosebruchEVP Chief Strategy Officer2020-11-246,900$98.83
$681.93kSell
Carlos AlbanVice Chairman2020-11-18115,830$35.88
$4.16MBuy
Carlos AlbanVice Chairman2020-11-18115,830$100.00
$11.58MSell
Richard A. GonzalezChairman of the Board and CEO2020-11-1285,057$54.86
$4.67MBuy
Richard A. GonzalezChairman of the Board and CEO2020-11-12109,097$58.88
$6.42MBuy
Richard A. GonzalezChairman of the Board and CEO2020-11-1216,171$97.49
$1.58MSell
Richard A. GonzalezChairman of the Board and CEO2020-11-12177,983$97.06
$17.28MSell
Azita SalekigerhardtEVP Operations2020-11-1217,426$98.00
$1.71MSell
Richard A. GonzalezChairman of the Board and CEO2020-11-1237,450$95.74
$3.59MSell

1 of 5

ABBV insiders have sold more ABBV shares than they have bought in the last year
Ownership

ABBV Shareholders

What type of owners hold AbbVie Inc stock?
Institutional
Insider
Retail
We're currently working to improve the accuracy of the Shareholders dataset. If you spot any inaccuracies, let us know at contact (at) wallstreetzen.com
NameHoldSharesValueType
Vanguard Group Inc8.18%144,334,850$15.14BInstitution
Blackrock Inc6.91%122,016,637$12.80BInstitution
State Street Corp4.43%78,208,461$8.20BInstitution
Capital Research Global Investors2.31%40,804,113$4.28BInstitution
Price T Rowe Associates Inc1.86%32,739,879$3.43BInstitution
Fmr LLC1.71%30,257,179$3.17BInstitution
Jpmorgan Chase Co1.65%29,190,573$3.06BInstitution
Geode Capital Management LLC1.48%26,135,072$2.74BInstitution
Northern Trust Corp1.38%24,363,192$2.56BInstitution
Berkshire Hathaway Inc1.20%21,264,316$2.23BInstitution

1 of 3

AbbVie Stock Ownership FAQ

AbbVie (NYSE: ABBV) is owned by 67.31% institutional shareholders, 0.11% AbbVie insiders, and 32.58% retail investors. Vanguard Group Inc is the largest individual AbbVie shareholder, owning 144.33M shares representing 8.18% of the company. Vanguard Group Inc's AbbVie shares are currently valued at $15.14B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics